Choreo LLC’s Castle Biosciences CSTL Stock Holding History

Choreo LLC’s Portfolio CSTL Stock Details CSTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,155	Closed	-$244K	–	1494
2024 Q4	$244K	Hold	9,155	–	–	﹤0.01%	1304
2024 Q3	$257K	Buy	+9,155	New	+$233K	﹤0.01%	1301

Other funds holding CSTL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Choreo LLC's CSTL Position: Q1 2025 in Review

Choreo LLC sold out of Castle Biosciences (CSTL) in Q1 2025, closing a stake of 9,155 shares — an estimated $244K sold.

Choreo LLC first reported a position in CSTL in Q3 2024 and held it in 2 quarters. The position peaked at $257K in Q3 2024. 180 funds tracked by Wall St. Rank hold CSTL as of Q1 2025.

Choreo LLC reported no remaining Castle Biosciences position as of Q1 2025 after selling out during the quarter.
Choreo LLC sold 9,155 Castle Biosciences shares in Q1 2025, an estimated $244K.
Choreo LLC first reported a position in Castle Biosciences in Q3 2024 and held it in 2 quarters.
Choreo LLC's Castle Biosciences position peaked at $257K in Q3 2024.
180 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2025.

Based on Choreo LLC's 13F filing for Q1 2025, filed 6 May 2025.